Solta Medical Clear + Brilliant and the Fraxel 1927
Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments will launch two new products at the 69th Annual Meeting of the American Academy of Dermatology (AAD) in New Orleans, Louisiana from February 4th through February 8th.
The international debut of Clear + Brilliant creates and defines an entirely new category of laser aesthetic treatments designed to meet the needs of consumers looking to take control of their aging process. Clear + Brilliant provides a new offering for physicians and other skin care providers to address evolving consumer needs and expand their patient base. In-depth research with patients and their skin care providers revealed an unmet need in the skin care continuum that lies between over the counter or spa treatments and far-reaching laser offerings such as Fraxel. These consumers would like a more efficacious treatment than their current regimens, but as of yet they don’t need the full transformative benefits of a more aggressive laser skin resurfacing procedure.� They are looking for that treatment that refreshes their skin and allows them to have control over their skin’s aging process.
“The Clear + Brilliant offering demonstrates Solta’s continued commitment to develop new products that meet the needs of skin care professionals and their patients,” said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. “It addresses a segment of the market that is not quite ready for more extensive procedures with an effective and affordable solution for more youthful looking skin. We are excited about the potential of this product to expand our patient base and generate incremental revenue for clinicians and for the Company.”
Clear + Brilliant is CE marked and the company plans to submit for FDA 510K clearance this month. The company expects to begin shipping the product to customers in certain international markets in the second quarter of 2011.
Solta will also be offering the groundbreaking Fraxel 1927 nm laser in a standalone package.� The 1927 nm wavelength was introduced last year as part of the Fraxel Dual platform and has quickly become the go-to wavelength for many practices around the world to address actinic keratosis, precancerous lesions on the skin, and other skin care conditions.
The Fraxel 1927 nm is authorized for sale in the U.S., Europe, and parts of Asia. The company expects to begin shipping the product to customers in March 2011.
“Clear + Brilliant and the Fraxel 1927 strengthen our product portfolio with solutions that continue to address the needs of patients and physicians with technologies that provide superior aesthetic and therapeutic benefits delivered in a simple and elegant manner. We expect that the introduction of these two new products will contribute to our growth in 2011 and beyond,” concluded Mr. Fanning. For more information visit: solta.com.
Related to Solta Medical Clear + Brilliant and the Fraxel 1927:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
[…] “Take a Swing at the Sun” is part of a larger Solta awareness campaign, in partnership with McCarron, to educate Tour players and fans on the prevention and treatment of sun damage.� Solta’s groundbreaking Fraxel 1927 nm laser was introduced last year as part of the Fraxel Dual platform and has quickly become the go-to wavelength for many practices around the world to address Actinic Keratoses (AK) or Solar Keratoses, precancerous skin conditions caused by the damaging effects of the sun.� McCarron received a Fraxel treatment as a patient, and experienced a significant reversal of sun damage. […]